Potential Allergens in Wine: Double-Blind Placebo-Controlled Trial - Tabular View

Home

Study Topics

Glossary


	Full Text View


	Tabular View


	Contacts and Locations


	No Study Results Posted


	Related Studies

Potential Allergens in Wine: Double-Blind Placebo-Controlled Trial

This study is currently recruiting participants.

Study NCT00163735. Last updated on November 6, 2006. Information provided by Bayside Health

This Tabular View shows the required WHO registration data elements as marked by ^†

Descriptive Information Fields

Brief Title ^†

Potential Allergens in Wine: Double-Blind Placebo-Controlled Trial

Official Title ^†

Potential Allergens in Wine: Double Blind Placebo-Controlled Trial and Basophil Activation Analysis

Brief Summary

This study is designed to identify whether wines which are produced using the common potential food allergens such as proteins derived from fish, milk or egg are likely to contain sufficient food allergens to cause allergic reactions in susceptible individuals.

Detailed Description

Recent international legislation requires labelling of wines made using potentially allergenic food proteins "casein", egg white, isinglass ( fish derived), milk or evaporated milk where "there is detectable residual processing aid". However it is not clear whether the final wine contains concentrations of residual added food proteins that can provoke allergic reactions.

Comparison:This study is a double blind, placebo-controlled trial to determine whether adults known to be allergic to eggs, fish, milk and/or nuts exhibit allergic reactions following consumption of Australian commercial wines fined with food allergens.

Study Phase

Study Type ^†

Interventional

Study Design ^†

Diagnostic, Randomized, Double-Blind, Placebo Control, Crossover Assignment, Safety Study

Primary Outcome Measure ^†

Allergic reactions to wine

Secondary Outcome Measure ^†

Positive basophil activiation test to wines

Condition ^†

Food Allergy
Anaphylaxis

Intervention ^†

Drug: Administration of wine fined with potential food allergens

MEDLINE PMIDs

Links

Recruitment Information Fields

Recruitment Status ^†

Recruiting

Enrollment ^†

Start Date ^†

August 2002

Completion Date

August 2006

Eligibility Criteria ^†

Inclusion Criteria:

Individuals with IgE-mediated food allergy to milk, fish, egg or nuts Otherwise no major medical problems Able to drink wine -

Exclusion Criteria:

Major asthma or cardiac disease Unwilling or unable to participate

Gender

Both

Ages

18 Years to 65 Years

Accepts Healthy Volunteers

Yes

Contacts ^††

Contact: Robyn E O'Hehir, MBBS FRACP PhD

++613 9276 2251

r.ohehir@alfred.org.au

Location Countries ^†

Australia

Administrative Information Fields

NCT ID ^†

NCT00163735

Organization ID

124/02

Secondary IDs ^††

Number 124/02

Study Sponsor ^†

Bayside Health

Collaborators ^††

The Australian Wine Research Institute, Adelaide
National Health and Medical Research Council, Australia
The Alfred

Investigators ^†

Study Director:	Robyn E O'Hehir, MBBS PhD FRACP	Alfred Hospital and Monash University
Principal Investigator:	Jennifer M Rolland, PhD	Monash University
Principal Investigator:	Creina S Stockley, PhD	The Australian Wine Research Institute

Information Provided By

Bayside Health

Verification Date

September 2005

First Received Date ^†

September 12, 2005

Last Updated Date

November 6, 2006

^† Required WHO trial registration data element.
^†† WHO trial registration data element that is required only if it exists.